Why IperionX (ASX:IPX) Is Down 5.7% After Titan DFS Unveils 14-Year U.S. Mine Plan

• Earlier in June 2026, IperionX released a Definitive Feasibility Study for its 100%-owned Titan Critical Minerals Project in Tennessee, outlining a 14-year mine plan, US$813 million after-tax NPV8, 39% after-tax IRR and phased development capital of US$381.30 million to produce titanium, zircon and heavy rare earth concentrate from a single U.S. resource.

• The Study positions Titan as a multi-critical-mineral platform for U.S. supply chains, with Phase 2 targeting annual output of titanium minerals, zircon and heavy rare earth concentrate containing dysprosium, terbium and yttrium, which are important for defense and high-tech applications.

• Against this backdrop and recent share price moves, we'll examine how the Titan Definitive Feasibility Study reshapes IperionX's investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

What Is IperionX's Investment Narrative?

To own IperionX, you really have to believe in its vision of a fully integrated U.S. titanium and critical minerals supply chain, built from Titan in Tennessee through to advanced manufacturing in Virginia. The Titan Definitive Feasibility Study sharpens that story by converting the project into a detailed, 14‑year mine plan with defined capital needs and economics, which now sits alongside recent U.S. Army fastener test results as a second, reinforcing pillar of the investment case. In the near term, the key catalysts look more tangible: securing project financing for the US$381.30 million Titan build, landing additional offtakes and scaling the Virginia campus. At the same time, the stock's recent volatility and lack of revenue keep funding risk, execution risk and potential shareholder dilution firmly in focus, even with the DFS in hand.

However, investors also need to consider how Titan's funding requirements could affect existing shareholders.IperionX's share price has been on the slide but might be dropping deeper into value territory. Find out whether it's a bargain at this price .

Exploring Other Perspectives

Three Simply Wall St Community fair value estimates for IperionX range from about A$2.88 to A$8.99, underlining how far apart private investors can be. Set against Titan's newly defined US$381.30 million funding task, these differing views highlight why it can pay to review multiple perspectives before forming your own.

Explore 3 other fair value estimates on IperionX - why the stock might be worth 44% less than the current price!